BDA-366, a putative Bcl-2 BH4 domain antagonist, induces apoptosis independently of Bcl-2 in a variety of cancer cell models

Several cancer cell types, including chronic lymphocytic leukemia (CLL) and diffuse large B-cell lymphoma (DLBCL) upregulate antiapoptotic Bcl-2 to cope with oncogenic stress. BH3 mimetics targeting Bcl-2’s hydrophobic cleft have been developed, including venetoclax as a promising anticancer precisi...

Descripción completa

Detalles Bibliográficos
Autores principales: Vervloessem, Tamara, Sasi, Binu K., Xerxa, Elena, Karamanou, Spyridoula, Kale, Justin, La Rovere, Rita M., Chakraborty, Supriya, Sneyers, Flore, Vogler, Meike, Economou, Anastassios, Laurenti, Luca, Andrews, David W., Efremov, Dimitar G., Bultynck, Geert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7498462/
https://www.ncbi.nlm.nih.gov/pubmed/32943617
http://dx.doi.org/10.1038/s41419-020-02944-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7498462/
https://www.ncbi.nlm.nih.gov/pubmed/32943617
http://dx.doi.org/10.1038/s41419-020-02944-6

Ejemplares similares